Company · CIK 0001631650
Aimmune Therapeutics, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- SC 13G/AAimmune Therapeutics, Inc.0001306923-21-000011 · 269.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-272122 · 258.2 KBSEC(opens sec.gov)
- SC 13D/AAimmune Therapeutics, Inc.0001193125-20-268119 · 79.7 KBSEC(opens sec.gov)
- SC 13D/AAimmune Therapeutics, Inc.0001193125-20-235338 · 97.0 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-20-235288 · 841.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0001564590-20-034973 · 11.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-034776 · 613.3 KBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-027348 · 185.6 KBSEC(opens sec.gov)
- 10-QQuarterly update0001564590-20-024196 · 9.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001564590-20-024181 · 506.9 KBSEC(opens sec.gov)
Insiders
- ADELMAN DANIEL C MDChief Medical Officer
- Barrowcliffe Susan E.General Manager, Europe
- Behar GregoryDirector
- BJERKHOLT ERICChief Financial Officer
- Dallas Jayson Donald AlexanderDirector, President and CEO
- DILLY STEPHEN GEORGEDirector, President and CEO
- ENRIGHT PATRICK GDirector
- FALBERG KATHRYN EDirector
- Foresite Capital Fund III, L.P.10% Owner
- Foresite Capital Fund II, L.P.10% Owner
Tickers
No tickers on record.
Addresses
business
8000 MARINA BOULEVARD SUITE 300
BRISBANE, CA, 94005-1884
mailing
8000 MARINA BOULEVARD SUITE 300
BRISBANE, CA, 94005-1884
Former names
- Allergen Research Corp2015-03-24
Same industry